Global Bacteriophage Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Bacteriophage Therapy market size was valued at US$ 31 million in 2023. With growing demand in downstream market, the Bacteriophage Therapy is forecast to a readjusted size of US$ 61 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Bacteriophage Therapy market. Bacteriophage Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Bacteriophage Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Bacteriophage Therapy market.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Bacteriophage Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Bacteriophage Therapy market. It may include historical data, market segmentation by Type (e.g., Oral, Topical), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Bacteriophage Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Bacteriophage Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Bacteriophage Therapy industry. This include advancements in Bacteriophage Therapy technology, Bacteriophage Therapy new entrants, Bacteriophage Therapy new investment, and other innovations that are shaping the future of Bacteriophage Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Bacteriophage Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Bacteriophage Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Bacteriophage Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Bacteriophage Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Bacteriophage Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Bacteriophage Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Bacteriophage Therapy market.
Market Segmentation:
Bacteriophage Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Bacteriophage Therapy market size was valued at US$ 31 million in 2023. With growing demand in downstream market, the Bacteriophage Therapy is forecast to a readjusted size of US$ 61 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Bacteriophage Therapy market. Bacteriophage Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Bacteriophage Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Bacteriophage Therapy market.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Bacteriophage Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Bacteriophage Therapy market. It may include historical data, market segmentation by Type (e.g., Oral, Topical), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Bacteriophage Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Bacteriophage Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Bacteriophage Therapy industry. This include advancements in Bacteriophage Therapy technology, Bacteriophage Therapy new entrants, Bacteriophage Therapy new investment, and other innovations that are shaping the future of Bacteriophage Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Bacteriophage Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Bacteriophage Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Bacteriophage Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Bacteriophage Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Bacteriophage Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Bacteriophage Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Bacteriophage Therapy market.
Market Segmentation:
Bacteriophage Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Oral
- Topical
- Parenteral
- Organ Transplantation
- Bacterial Infections
- Alcoholic Hepatitis
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd.
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH.
- PhagePro, Inc.
- Adaptive Phage Therapeutics, Inc.
- EnBiotix, Inc.
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd.
- Micreos BV
- ContraFect Corporation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bacteriophage Therapy Market Size 2019-2030
2.1.2 Bacteriophage Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Bacteriophage Therapy Segment by Type
2.2.1 Oral
2.2.2 Topical
2.2.3 Parenteral
2.3 Bacteriophage Therapy Market Size by Type
2.3.1 Bacteriophage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
2.4 Bacteriophage Therapy Segment by Application
2.4.1 Organ Transplantation
2.4.2 Bacterial Infections
2.4.3 Alcoholic Hepatitis
2.4.4 Other
2.5 Bacteriophage Therapy Market Size by Application
2.5.1 Bacteriophage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
3 BACTERIOPHAGE THERAPY MARKET SIZE BY PLAYER
3.1 Bacteriophage Therapy Market Size Market Share by Players
3.1.1 Global Bacteriophage Therapy Revenue by Players (2019-2024)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bacteriophage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BACTERIOPHAGE THERAPY BY REGIONS
4.1 Bacteriophage Therapy Market Size by Regions (2019-2024)
4.2 Americas Bacteriophage Therapy Market Size Growth (2019-2024)
4.3 APAC Bacteriophage Therapy Market Size Growth (2019-2024)
4.4 Europe Bacteriophage Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Bacteriophage Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Bacteriophage Therapy Market Size by Country (2019-2024)
5.2 Americas Bacteriophage Therapy Market Size by Type (2019-2024)
5.3 Americas Bacteriophage Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophage Therapy Market Size by Region (2019-2024)
6.2 APAC Bacteriophage Therapy Market Size by Type (2019-2024)
6.3 APAC Bacteriophage Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bacteriophage Therapy by Country (2019-2024)
7.2 Europe Bacteriophage Therapy Market Size by Type (2019-2024)
7.3 Europe Bacteriophage Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bacteriophage Therapy by Region (2019-2024)
8.2 Middle East & Africa Bacteriophage Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Bacteriophage Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BACTERIOPHAGE THERAPY MARKET FORECAST
10.1 Global Bacteriophage Therapy Forecast by Regions (2025-2030)
10.1.1 Global Bacteriophage Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Bacteriophage Therapy Forecast
10.1.3 APAC Bacteriophage Therapy Forecast
10.1.4 Europe Bacteriophage Therapy Forecast
10.1.5 Middle East & Africa Bacteriophage Therapy Forecast
10.2 Americas Bacteriophage Therapy Forecast by Country (2025-2030)
10.2.1 United States Bacteriophage Therapy Market Forecast
10.2.2 Canada Bacteriophage Therapy Market Forecast
10.2.3 Mexico Bacteriophage Therapy Market Forecast
10.2.4 Brazil Bacteriophage Therapy Market Forecast
10.3 APAC Bacteriophage Therapy Forecast by Region (2025-2030)
10.3.1 China Bacteriophage Therapy Market Forecast
10.3.2 Japan Bacteriophage Therapy Market Forecast
10.3.3 Korea Bacteriophage Therapy Market Forecast
10.3.4 Southeast Asia Bacteriophage Therapy Market Forecast
10.3.5 India Bacteriophage Therapy Market Forecast
10.3.6 Australia Bacteriophage Therapy Market Forecast
10.4 Europe Bacteriophage Therapy Forecast by Country (2025-2030)
10.4.1 Germany Bacteriophage Therapy Market Forecast
10.4.2 France Bacteriophage Therapy Market Forecast
10.4.3 UK Bacteriophage Therapy Market Forecast
10.4.4 Italy Bacteriophage Therapy Market Forecast
10.4.5 Russia Bacteriophage Therapy Market Forecast
10.5 Middle East & Africa Bacteriophage Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Bacteriophage Therapy Market Forecast
10.5.2 South Africa Bacteriophage Therapy Market Forecast
10.5.3 Israel Bacteriophage Therapy Market Forecast
10.5.4 Turkey Bacteriophage Therapy Market Forecast
10.5.5 GCC Countries Bacteriophage Therapy Market Forecast
10.6 Global Bacteriophage Therapy Forecast by Type (2025-2030)
10.7 Global Bacteriophage Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Information
11.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.1.5 Armata Pharmaceuticals, Inc. Latest Developments
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Information
11.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eliava Biopreparations Ltd. Main Business Overview
11.2.5 Eliava Biopreparations Ltd. Latest Developments
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Information
11.3.2 Pherecydes Pharma Bacteriophage Therapy Product Offered
11.3.3 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pherecydes Pharma Main Business Overview
11.3.5 Pherecydes Pharma Latest Developments
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Information
11.4.2 Intralytix, Inc. Bacteriophage Therapy Product Offered
11.4.3 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intralytix, Inc. Main Business Overview
11.4.5 Intralytix, Inc. Latest Developments
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Information
11.5.2 Phagelux Inc. Bacteriophage Therapy Product Offered
11.5.3 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Phagelux Inc. Main Business Overview
11.5.5 Phagelux Inc. Latest Developments
11.6 Nextbiotics
11.6.1 Nextbiotics Company Information
11.6.2 Nextbiotics Bacteriophage Therapy Product Offered
11.6.3 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Nextbiotics Main Business Overview
11.6.5 Nextbiotics Latest Developments
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Information
11.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Offered
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 InnoPhage, Ltd Main Business Overview
11.7.5 InnoPhage, Ltd Latest Developments
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Information
11.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Locus Biosciences, Inc. Main Business Overview
11.8.5 Locus Biosciences, Inc. Latest Developments
11.9 TechnoPhage
11.9.1 TechnoPhage Company Information
11.9.2 TechnoPhage Bacteriophage Therapy Product Offered
11.9.3 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TechnoPhage Main Business Overview
11.9.5 TechnoPhage Latest Developments
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Information
11.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Offered
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eligo Bioscience SA Main Business Overview
11.10.5 Eligo Bioscience SA Latest Developments
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Information
11.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Phagomed Biopharma GmbH. Main Business Overview
11.11.5 Phagomed Biopharma GmbH. Latest Developments
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Information
11.12.2 PhagePro, Inc. Bacteriophage Therapy Product Offered
11.12.3 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 PhagePro, Inc. Main Business Overview
11.12.5 PhagePro, Inc. Latest Developments
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Information
11.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Adaptive Phage Therapeutics, Inc. Main Business Overview
11.13.5 Adaptive Phage Therapeutics, Inc. Latest Developments
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Information
11.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Offered
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 EnBiotix, Inc. Main Business Overview
11.14.5 EnBiotix, Inc. Latest Developments
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Information
11.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Offered
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Intodeworld, Inc. Main Business Overview
11.15.5 Intodeworld, Inc. Latest Developments
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Information
11.16.2 BiomX Ltd. Bacteriophage Therapy Product Offered
11.16.3 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BiomX Ltd. Main Business Overview
11.16.5 BiomX Ltd. Latest Developments
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Information
11.17.2 Phi Therapeutics Bacteriophage Therapy Product Offered
11.17.3 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Phi Therapeutics Main Business Overview
11.17.5 Phi Therapeutics Latest Developments
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Information
11.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Offered
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Fixed-phage Ltd. Main Business Overview
11.18.5 Fixed-phage Ltd. Latest Developments
11.19 Micreos BV
11.19.1 Micreos BV Company Information
11.19.2 Micreos BV Bacteriophage Therapy Product Offered
11.19.3 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Micreos BV Main Business Overview
11.19.5 Micreos BV Latest Developments
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Information
11.20.2 ContraFect Corporation Bacteriophage Therapy Product Offered
11.20.3 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 ContraFect Corporation Main Business Overview
11.20.5 ContraFect Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bacteriophage Therapy Market Size 2019-2030
2.1.2 Bacteriophage Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Bacteriophage Therapy Segment by Type
2.2.1 Oral
2.2.2 Topical
2.2.3 Parenteral
2.3 Bacteriophage Therapy Market Size by Type
2.3.1 Bacteriophage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
2.4 Bacteriophage Therapy Segment by Application
2.4.1 Organ Transplantation
2.4.2 Bacterial Infections
2.4.3 Alcoholic Hepatitis
2.4.4 Other
2.5 Bacteriophage Therapy Market Size by Application
2.5.1 Bacteriophage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
3 BACTERIOPHAGE THERAPY MARKET SIZE BY PLAYER
3.1 Bacteriophage Therapy Market Size Market Share by Players
3.1.1 Global Bacteriophage Therapy Revenue by Players (2019-2024)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bacteriophage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BACTERIOPHAGE THERAPY BY REGIONS
4.1 Bacteriophage Therapy Market Size by Regions (2019-2024)
4.2 Americas Bacteriophage Therapy Market Size Growth (2019-2024)
4.3 APAC Bacteriophage Therapy Market Size Growth (2019-2024)
4.4 Europe Bacteriophage Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Bacteriophage Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Bacteriophage Therapy Market Size by Country (2019-2024)
5.2 Americas Bacteriophage Therapy Market Size by Type (2019-2024)
5.3 Americas Bacteriophage Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophage Therapy Market Size by Region (2019-2024)
6.2 APAC Bacteriophage Therapy Market Size by Type (2019-2024)
6.3 APAC Bacteriophage Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Bacteriophage Therapy by Country (2019-2024)
7.2 Europe Bacteriophage Therapy Market Size by Type (2019-2024)
7.3 Europe Bacteriophage Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bacteriophage Therapy by Region (2019-2024)
8.2 Middle East & Africa Bacteriophage Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Bacteriophage Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BACTERIOPHAGE THERAPY MARKET FORECAST
10.1 Global Bacteriophage Therapy Forecast by Regions (2025-2030)
10.1.1 Global Bacteriophage Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Bacteriophage Therapy Forecast
10.1.3 APAC Bacteriophage Therapy Forecast
10.1.4 Europe Bacteriophage Therapy Forecast
10.1.5 Middle East & Africa Bacteriophage Therapy Forecast
10.2 Americas Bacteriophage Therapy Forecast by Country (2025-2030)
10.2.1 United States Bacteriophage Therapy Market Forecast
10.2.2 Canada Bacteriophage Therapy Market Forecast
10.2.3 Mexico Bacteriophage Therapy Market Forecast
10.2.4 Brazil Bacteriophage Therapy Market Forecast
10.3 APAC Bacteriophage Therapy Forecast by Region (2025-2030)
10.3.1 China Bacteriophage Therapy Market Forecast
10.3.2 Japan Bacteriophage Therapy Market Forecast
10.3.3 Korea Bacteriophage Therapy Market Forecast
10.3.4 Southeast Asia Bacteriophage Therapy Market Forecast
10.3.5 India Bacteriophage Therapy Market Forecast
10.3.6 Australia Bacteriophage Therapy Market Forecast
10.4 Europe Bacteriophage Therapy Forecast by Country (2025-2030)
10.4.1 Germany Bacteriophage Therapy Market Forecast
10.4.2 France Bacteriophage Therapy Market Forecast
10.4.3 UK Bacteriophage Therapy Market Forecast
10.4.4 Italy Bacteriophage Therapy Market Forecast
10.4.5 Russia Bacteriophage Therapy Market Forecast
10.5 Middle East & Africa Bacteriophage Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Bacteriophage Therapy Market Forecast
10.5.2 South Africa Bacteriophage Therapy Market Forecast
10.5.3 Israel Bacteriophage Therapy Market Forecast
10.5.4 Turkey Bacteriophage Therapy Market Forecast
10.5.5 GCC Countries Bacteriophage Therapy Market Forecast
10.6 Global Bacteriophage Therapy Forecast by Type (2025-2030)
10.7 Global Bacteriophage Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Information
11.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.1.5 Armata Pharmaceuticals, Inc. Latest Developments
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Information
11.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eliava Biopreparations Ltd. Main Business Overview
11.2.5 Eliava Biopreparations Ltd. Latest Developments
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Information
11.3.2 Pherecydes Pharma Bacteriophage Therapy Product Offered
11.3.3 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pherecydes Pharma Main Business Overview
11.3.5 Pherecydes Pharma Latest Developments
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Information
11.4.2 Intralytix, Inc. Bacteriophage Therapy Product Offered
11.4.3 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intralytix, Inc. Main Business Overview
11.4.5 Intralytix, Inc. Latest Developments
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Information
11.5.2 Phagelux Inc. Bacteriophage Therapy Product Offered
11.5.3 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Phagelux Inc. Main Business Overview
11.5.5 Phagelux Inc. Latest Developments
11.6 Nextbiotics
11.6.1 Nextbiotics Company Information
11.6.2 Nextbiotics Bacteriophage Therapy Product Offered
11.6.3 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Nextbiotics Main Business Overview
11.6.5 Nextbiotics Latest Developments
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Information
11.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Offered
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 InnoPhage, Ltd Main Business Overview
11.7.5 InnoPhage, Ltd Latest Developments
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Information
11.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Locus Biosciences, Inc. Main Business Overview
11.8.5 Locus Biosciences, Inc. Latest Developments
11.9 TechnoPhage
11.9.1 TechnoPhage Company Information
11.9.2 TechnoPhage Bacteriophage Therapy Product Offered
11.9.3 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TechnoPhage Main Business Overview
11.9.5 TechnoPhage Latest Developments
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Information
11.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Offered
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eligo Bioscience SA Main Business Overview
11.10.5 Eligo Bioscience SA Latest Developments
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Information
11.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Phagomed Biopharma GmbH. Main Business Overview
11.11.5 Phagomed Biopharma GmbH. Latest Developments
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Information
11.12.2 PhagePro, Inc. Bacteriophage Therapy Product Offered
11.12.3 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 PhagePro, Inc. Main Business Overview
11.12.5 PhagePro, Inc. Latest Developments
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Information
11.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Adaptive Phage Therapeutics, Inc. Main Business Overview
11.13.5 Adaptive Phage Therapeutics, Inc. Latest Developments
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Information
11.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Offered
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 EnBiotix, Inc. Main Business Overview
11.14.5 EnBiotix, Inc. Latest Developments
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Information
11.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Offered
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Intodeworld, Inc. Main Business Overview
11.15.5 Intodeworld, Inc. Latest Developments
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Information
11.16.2 BiomX Ltd. Bacteriophage Therapy Product Offered
11.16.3 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BiomX Ltd. Main Business Overview
11.16.5 BiomX Ltd. Latest Developments
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Information
11.17.2 Phi Therapeutics Bacteriophage Therapy Product Offered
11.17.3 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Phi Therapeutics Main Business Overview
11.17.5 Phi Therapeutics Latest Developments
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Information
11.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Offered
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Fixed-phage Ltd. Main Business Overview
11.18.5 Fixed-phage Ltd. Latest Developments
11.19 Micreos BV
11.19.1 Micreos BV Company Information
11.19.2 Micreos BV Bacteriophage Therapy Product Offered
11.19.3 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Micreos BV Main Business Overview
11.19.5 Micreos BV Latest Developments
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Information
11.20.2 ContraFect Corporation Bacteriophage Therapy Product Offered
11.20.3 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 ContraFect Corporation Main Business Overview
11.20.5 ContraFect Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Bacteriophage Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Topical
Table 4. Major Players of Parenteral
Table 5. Bacteriophage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 8. Bacteriophage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 11. Global Bacteriophage Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Bacteriophage Therapy Revenue Market Share by Player (2019-2024)
Table 13. Bacteriophage Therapy Key Players Head office and Products Offered
Table 14. Bacteriophage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Bacteriophage Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Bacteriophage Therapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Bacteriophage Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Bacteriophage Therapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Bacteriophage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Bacteriophage Therapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Bacteriophage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Bacteriophage Therapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Bacteriophage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Bacteriophage Therapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Bacteriophage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Bacteriophage Therapy
Table 46. Key Market Challenges & Risks of Bacteriophage Therapy
Table 47. Key Industry Trends of Bacteriophage Therapy
Table 48. Global Bacteriophage Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Bacteriophage Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Bacteriophage Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Bacteriophage Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Armata Pharmaceuticals, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 53. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
Table 54. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Armata Pharmaceuticals, Inc. Main Business
Table 56. Armata Pharmaceuticals, Inc. Latest Developments
Table 57. Eliava Biopreparations Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 58. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
Table 59. Eliava Biopreparations Ltd. Main Business
Table 60. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Eliava Biopreparations Ltd. Latest Developments
Table 62. Pherecydes Pharma Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 63. Pherecydes Pharma Bacteriophage Therapy Product Offered
Table 64. Pherecydes Pharma Main Business
Table 65. Pherecydes Pharma Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Pherecydes Pharma Latest Developments
Table 67. Intralytix, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 68. Intralytix, Inc. Bacteriophage Therapy Product Offered
Table 69. Intralytix, Inc. Main Business
Table 70. Intralytix, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Intralytix, Inc. Latest Developments
Table 72. Phagelux Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 73. Phagelux Inc. Bacteriophage Therapy Product Offered
Table 74. Phagelux Inc. Main Business
Table 75. Phagelux Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Phagelux Inc. Latest Developments
Table 77. Nextbiotics Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 78. Nextbiotics Bacteriophage Therapy Product Offered
Table 79. Nextbiotics Main Business
Table 80. Nextbiotics Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Nextbiotics Latest Developments
Table 82. InnoPhage, Ltd Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 83. InnoPhage, Ltd Bacteriophage Therapy Product Offered
Table 84. InnoPhage, Ltd Main Business
Table 85. InnoPhage, Ltd Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. InnoPhage, Ltd Latest Developments
Table 87. Locus Biosciences, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 88. Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
Table 89. Locus Biosciences, Inc. Main Business
Table 90. Locus Biosciences, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Locus Biosciences, Inc. Latest Developments
Table 92. TechnoPhage Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 93. TechnoPhage Bacteriophage Therapy Product Offered
Table 94. TechnoPhage Main Business
Table 95. TechnoPhage Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. TechnoPhage Latest Developments
Table 97. Eligo Bioscience SA Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 98. Eligo Bioscience SA Bacteriophage Therapy Product Offered
Table 99. Eligo Bioscience SA Main Business
Table 100. Eligo Bioscience SA Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Eligo Bioscience SA Latest Developments
Table 102. Phagomed Biopharma GmbH. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 103. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered
Table 104. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Phagomed Biopharma GmbH. Main Business
Table 106. Phagomed Biopharma GmbH. Latest Developments
Table 107. PhagePro, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 108. PhagePro, Inc. Bacteriophage Therapy Product Offered
Table 109. PhagePro, Inc. Main Business
Table 110. PhagePro, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. PhagePro, Inc. Latest Developments
Table 112. Adaptive Phage Therapeutics, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 113. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered
Table 114. Adaptive Phage Therapeutics, Inc. Main Business
Table 115. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Adaptive Phage Therapeutics, Inc. Latest Developments
Table 117. EnBiotix, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 118. EnBiotix, Inc. Bacteriophage Therapy Product Offered
Table 119. EnBiotix, Inc. Main Business
Table 120. EnBiotix, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. EnBiotix, Inc. Latest Developments
Table 122. Intodeworld, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 123. Intodeworld, Inc. Bacteriophage Therapy Product Offered
Table 124. Intodeworld, Inc. Main Business
Table 125. Intodeworld, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Intodeworld, Inc. Latest Developments
Table 127. BiomX Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 128. BiomX Ltd. Bacteriophage Therapy Product Offered
Table 129. BiomX Ltd. Main Business
Table 130. BiomX Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. BiomX Ltd. Latest Developments
Table 132. Phi Therapeutics Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 133. Phi Therapeutics Bacteriophage Therapy Product Offered
Table 134. Phi Therapeutics Main Business
Table 135. Phi Therapeutics Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Phi Therapeutics Latest Developments
Table 137. Fixed-phage Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 138. Fixed-phage Ltd. Bacteriophage Therapy Product Offered
Table 139. Fixed-phage Ltd. Main Business
Table 140. Fixed-phage Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Fixed-phage Ltd. Latest Developments
Table 142. Micreos BV Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 143. Micreos BV Bacteriophage Therapy Product Offered
Table 144. Micreos BV Main Business
Table 145. Micreos BV Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Micreos BV Latest Developments
Table 147. ContraFect Corporation Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 148. ContraFect Corporation Bacteriophage Therapy Product Offered
Table 149. ContraFect Corporation Main Business
Table 150. ContraFect Corporation Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. ContraFect Corporation Latest Developments
.
Table 1. Bacteriophage Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Topical
Table 4. Major Players of Parenteral
Table 5. Bacteriophage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 8. Bacteriophage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 11. Global Bacteriophage Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Bacteriophage Therapy Revenue Market Share by Player (2019-2024)
Table 13. Bacteriophage Therapy Key Players Head office and Products Offered
Table 14. Bacteriophage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Bacteriophage Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Bacteriophage Therapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Bacteriophage Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Bacteriophage Therapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Bacteriophage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Bacteriophage Therapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Bacteriophage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Bacteriophage Therapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Bacteriophage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Bacteriophage Therapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Bacteriophage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Bacteriophage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Bacteriophage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Bacteriophage Therapy
Table 46. Key Market Challenges & Risks of Bacteriophage Therapy
Table 47. Key Industry Trends of Bacteriophage Therapy
Table 48. Global Bacteriophage Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Bacteriophage Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Bacteriophage Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Bacteriophage Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Armata Pharmaceuticals, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 53. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
Table 54. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Armata Pharmaceuticals, Inc. Main Business
Table 56. Armata Pharmaceuticals, Inc. Latest Developments
Table 57. Eliava Biopreparations Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 58. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
Table 59. Eliava Biopreparations Ltd. Main Business
Table 60. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Eliava Biopreparations Ltd. Latest Developments
Table 62. Pherecydes Pharma Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 63. Pherecydes Pharma Bacteriophage Therapy Product Offered
Table 64. Pherecydes Pharma Main Business
Table 65. Pherecydes Pharma Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Pherecydes Pharma Latest Developments
Table 67. Intralytix, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 68. Intralytix, Inc. Bacteriophage Therapy Product Offered
Table 69. Intralytix, Inc. Main Business
Table 70. Intralytix, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Intralytix, Inc. Latest Developments
Table 72. Phagelux Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 73. Phagelux Inc. Bacteriophage Therapy Product Offered
Table 74. Phagelux Inc. Main Business
Table 75. Phagelux Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Phagelux Inc. Latest Developments
Table 77. Nextbiotics Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 78. Nextbiotics Bacteriophage Therapy Product Offered
Table 79. Nextbiotics Main Business
Table 80. Nextbiotics Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Nextbiotics Latest Developments
Table 82. InnoPhage, Ltd Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 83. InnoPhage, Ltd Bacteriophage Therapy Product Offered
Table 84. InnoPhage, Ltd Main Business
Table 85. InnoPhage, Ltd Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. InnoPhage, Ltd Latest Developments
Table 87. Locus Biosciences, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 88. Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
Table 89. Locus Biosciences, Inc. Main Business
Table 90. Locus Biosciences, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Locus Biosciences, Inc. Latest Developments
Table 92. TechnoPhage Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 93. TechnoPhage Bacteriophage Therapy Product Offered
Table 94. TechnoPhage Main Business
Table 95. TechnoPhage Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. TechnoPhage Latest Developments
Table 97. Eligo Bioscience SA Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 98. Eligo Bioscience SA Bacteriophage Therapy Product Offered
Table 99. Eligo Bioscience SA Main Business
Table 100. Eligo Bioscience SA Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Eligo Bioscience SA Latest Developments
Table 102. Phagomed Biopharma GmbH. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 103. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered
Table 104. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Phagomed Biopharma GmbH. Main Business
Table 106. Phagomed Biopharma GmbH. Latest Developments
Table 107. PhagePro, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 108. PhagePro, Inc. Bacteriophage Therapy Product Offered
Table 109. PhagePro, Inc. Main Business
Table 110. PhagePro, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. PhagePro, Inc. Latest Developments
Table 112. Adaptive Phage Therapeutics, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 113. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered
Table 114. Adaptive Phage Therapeutics, Inc. Main Business
Table 115. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Adaptive Phage Therapeutics, Inc. Latest Developments
Table 117. EnBiotix, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 118. EnBiotix, Inc. Bacteriophage Therapy Product Offered
Table 119. EnBiotix, Inc. Main Business
Table 120. EnBiotix, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. EnBiotix, Inc. Latest Developments
Table 122. Intodeworld, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 123. Intodeworld, Inc. Bacteriophage Therapy Product Offered
Table 124. Intodeworld, Inc. Main Business
Table 125. Intodeworld, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Intodeworld, Inc. Latest Developments
Table 127. BiomX Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 128. BiomX Ltd. Bacteriophage Therapy Product Offered
Table 129. BiomX Ltd. Main Business
Table 130. BiomX Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. BiomX Ltd. Latest Developments
Table 132. Phi Therapeutics Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 133. Phi Therapeutics Bacteriophage Therapy Product Offered
Table 134. Phi Therapeutics Main Business
Table 135. Phi Therapeutics Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. Phi Therapeutics Latest Developments
Table 137. Fixed-phage Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 138. Fixed-phage Ltd. Bacteriophage Therapy Product Offered
Table 139. Fixed-phage Ltd. Main Business
Table 140. Fixed-phage Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Fixed-phage Ltd. Latest Developments
Table 142. Micreos BV Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 143. Micreos BV Bacteriophage Therapy Product Offered
Table 144. Micreos BV Main Business
Table 145. Micreos BV Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. Micreos BV Latest Developments
Table 147. ContraFect Corporation Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors
Table 148. ContraFect Corporation Bacteriophage Therapy Product Offered
Table 149. ContraFect Corporation Main Business
Table 150. ContraFect Corporation Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. ContraFect Corporation Latest Developments
LIST OF FIGURES
.
Figure 1. Bacteriophage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bacteriophage Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Bacteriophage Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Bacteriophage Therapy Sales Market Share by Country/Region (2023)
Figure 8. Bacteriophage Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Bacteriophage Therapy Market Size Market Share by Type in 2023
Figure 10. Bacteriophage Therapy in Organ Transplantation
Figure 11. Global Bacteriophage Therapy Market: Organ Transplantation (2019-2024) & ($ Millions)
Figure 12. Bacteriophage Therapy in Bacterial Infections
Figure 13. Global Bacteriophage Therapy Market: Bacterial Infections (2019-2024) & ($ Millions)
Figure 14. Bacteriophage Therapy in Alcoholic Hepatitis
Figure 15. Global Bacteriophage Therapy Market: Alcoholic Hepatitis (2019-2024) & ($ Millions)
Figure 16. Bacteriophage Therapy in Other
Figure 17. Global Bacteriophage Therapy Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Bacteriophage Therapy Market Size Market Share by Application in 2023
Figure 19. Global Bacteriophage Therapy Revenue Market Share by Player in 2023
Figure 20. Global Bacteriophage Therapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas Bacteriophage Therapy Value Market Share by Country in 2023
Figure 26. United States Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Bacteriophage Therapy Market Size Market Share by Region in 2023
Figure 31. APAC Bacteriophage Therapy Market Size Market Share by Type in 2023
Figure 32. APAC Bacteriophage Therapy Market Size Market Share by Application in 2023
Figure 33. China Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Bacteriophage Therapy Market Size Market Share by Country in 2023
Figure 40. Europe Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 59. United States Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 63. China Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 67. India Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 70. France Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 71. UK Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 80. Global Bacteriophage Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Bacteriophage Therapy Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Bacteriophage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bacteriophage Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Bacteriophage Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Bacteriophage Therapy Sales Market Share by Country/Region (2023)
Figure 8. Bacteriophage Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Bacteriophage Therapy Market Size Market Share by Type in 2023
Figure 10. Bacteriophage Therapy in Organ Transplantation
Figure 11. Global Bacteriophage Therapy Market: Organ Transplantation (2019-2024) & ($ Millions)
Figure 12. Bacteriophage Therapy in Bacterial Infections
Figure 13. Global Bacteriophage Therapy Market: Bacterial Infections (2019-2024) & ($ Millions)
Figure 14. Bacteriophage Therapy in Alcoholic Hepatitis
Figure 15. Global Bacteriophage Therapy Market: Alcoholic Hepatitis (2019-2024) & ($ Millions)
Figure 16. Bacteriophage Therapy in Other
Figure 17. Global Bacteriophage Therapy Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Bacteriophage Therapy Market Size Market Share by Application in 2023
Figure 19. Global Bacteriophage Therapy Revenue Market Share by Player in 2023
Figure 20. Global Bacteriophage Therapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Bacteriophage Therapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas Bacteriophage Therapy Value Market Share by Country in 2023
Figure 26. United States Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Bacteriophage Therapy Market Size Market Share by Region in 2023
Figure 31. APAC Bacteriophage Therapy Market Size Market Share by Type in 2023
Figure 32. APAC Bacteriophage Therapy Market Size Market Share by Application in 2023
Figure 33. China Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Bacteriophage Therapy Market Size Market Share by Country in 2023
Figure 40. Europe Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Bacteriophage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 59. United States Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 63. China Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 67. India Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 70. France Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 71. UK Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Bacteriophage Therapy Market Size 2025-2030 ($ Millions)
Figure 80. Global Bacteriophage Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Bacteriophage Therapy Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Cardiorespiratory Stress Test Equipment Market Growth 2023-2029
US$ 3,660.00
February 2023
113 pages
Global 3D Cell Culture Market Growth 2025-2031
US$ 3,660.00
March 2025
106 pages
Global Patient Barrier Aprons Market Growth 2023-2029
US$ 3,660.00
February 2023
97 pages
Global 3D Medical Implant Market Growth 2024-2030
US$ 3,660.00
December 2024
113 pages
Global Posture-correcting Orthose Market Growth 2024-2030
US$ 3,660.00
March 2024
97 pages
